Tmph1980 Posted Wednesday at 03:19 PM Share Posted Wednesday at 03:19 PM My mom was diagnosed with combined SCLC, and the pathology said it was POU2F3+, meaning I believe she is subtyped at SCLC-P. I did a massive amount of research yesterday. Each subtype has been shown to respond to different things. We meet with the thoracic oncologist on Monday, and I just want to be armed with information. Are these subtypes typically discussed with doctors? For example, the SCLC-P subtype has been show to be sensitive to PARP inhibitors as well as lurbinectedin (Zepzelca). There has been some other new information published in the last few months an about other potential treatment targets for this subtype. I want to best advocate for my mom, and I’m just wondering if this is something that is typically discussed. Quote Link to comment Share on other sites More sharing options...
edivebuddy Posted Wednesday at 03:59 PM Share Posted Wednesday at 03:59 PM Sorry you guys are going through this. I don't have much knowledge on small cell so all I can't off much. Small Cell seems to be getting lots more attention these days and hopefully it pays off for your mom Tmph1980 1 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.